Lonza Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH) and Portsmouth (US)

. Lonza will invest approximately CHF 850 million to build two new state-of-the-art mammalian facilities and respond to customer demand regarding capacity, life cycle management and speed to market A new large-scale facility with the latest manufacturing technology in Visp Read More

Business figures for the first three months of 2021: Basler AG closes the first quarter with strong growth, high profitability and positive outlook

. – Incoming orders: € 67.3 million (previous year: € 52.9 million, +27 %) – Sales: € 54.6 million (previous year: € 43.7 million, +25 %) – EBITDA: € 14.7 million (previous year: € 9.5 million, +55 %) – Pre-tax Read More

Vegetable oil prices continue to rise

. Generally tense supply on the international oilseed market with mostly strong prices has fuelled prices of the most important vegetable oils. Vegetable oil prices in April reached their highest level on record since Agrarmarkt Informations-Gesellschaft (mbH) started recording in Read More

SIG announces launch of tethered caps for carton packs three years ahead of EU regulatory requirements

. SIG announced today that tethered caps will be launched for its beverage cartons in Europe in the second half of 2021, well ahead of the July 2024 deadline set by EU regulations. The redesigned caps do not compromise on Read More

Basler AG publishes preliminary figures for the first quarter and increases the annual forecast for financial year 2021

Today, BASLER AG, a leading manufacturer of computer vision components, publishes its preliminary result for the first quarter of 2021 and adjusts its sales and profit forecast for financial year 2021 upwards. The Basler group closed the first three months Read More

Mr. Marius Muehlenberg – the new CEO of LEVACO Chemicals Group and LEVACO Chemicals GmbH

From 1st of May 2021, Mr. Marius Muehlenberg, already CEO of DEFOTEC Entschäumer Vertriebs-GmbH, will start as well in his position as CEO of the LEVACO Chemicals Group and the LEVACO Chemicals GmbH. He will be heading the group of Read More

Studie untersucht den Wert von Bewegungstherapie bei krebskranken Kindern

Eine Bewegungstherapie kann die Lebensqualität und Leistungsfähigkeit von Krebskranken verbessern und steigert die Erfolgschancen der onkologischen Behandlung. Bei krebskranken Kindern und Jugendlichen ist die Datenlage bezüglich dieses Effekts jedoch noch spärlich. Daher wird eine Bewegungstherapie bei ihnen eher selten verordnet. Read More